Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

EU Member States Modify Rules On Microorganisms

Feb. 28, 2001

By Peter O'Donnell

EU Parliament, Ministers Agree To New Rules Covering Biotech

Feb. 21, 2001

By Peter O'Donnell

Sweden Plans To Use Presidency To Improve Biotechnology Climate

Feb. 21, 2001

By Peter O'Donnell

EU Parliament, Ministers Agree To New Rules Covering Biotech

Feb. 21, 2001

By Peter O'Donnell

Sweden Plans To Use Presidency To Improve Biotechnology Climate

Feb. 21, 2001

By Peter O'Donnell

Parliament Committee Urges Caution In EU Biotech Industry

Feb. 7, 2001

By Peter O'Donnell

Ethics Expert Describes EU Biotechnology 'Culture Shock'

Feb. 7, 2001

By Peter O'Donnell

Ethics Expert Describes EU Biotechnology 'Culture Shock'

Feb. 7, 2001

By Peter O'Donnell

Parliament Committee Urges Caution In EU Biotech Industry

Feb. 7, 2001

By Peter O'Donnell

Draft Report Sparks Debate Among European Ministers

Jan. 31, 2001

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...